177 related articles for article (PubMed ID: 31375151)
1. Lipoxygenase-5 Expression in Canine Urinary Bladder: Normal Urothelium, Cystitis and Transitional Cell Carcinoma.
Finotello R; Schiavo L; Ressel L; Frohmader A; Silvestrini P; Verin R
J Comp Pathol; 2019 Jul; 170():1-9. PubMed ID: 31375151
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of p63, Ki67 and β-catenin in canine transitional cell carcinoma and polypoid cystitis of the urinary bladder.
Hanazono K; Nishimori T; Fukumoto S; Kawamura Y; Endo Y; Kadosawa T; Uchide T
Vet Comp Oncol; 2016 Sep; 14(3):263-9. PubMed ID: 24758385
[TBL] [Abstract][Full Text] [Related]
3. Comparison of distributions of survivin among tissues from urinary bladders of dogs with cystitis, transitional cell carcinoma, or histologically normal urinary bladders.
Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Green JA
Am J Vet Res; 2008 Aug; 69(8):1073-8. PubMed ID: 18672973
[TBL] [Abstract][Full Text] [Related]
4. Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma.
Vinall RL; Kent MS; deVere White RW
Am J Vet Res; 2012 Oct; 73(10):1626-33. PubMed ID: 23013190
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclooxygenase-2 in transitional cell carcinoma of the urinary bladder in dogs.
Khan KN; Knapp DW; Denicola DB; Harris RK
Am J Vet Res; 2000 May; 61(5):478-81. PubMed ID: 10803639
[TBL] [Abstract][Full Text] [Related]
6. Expression of receptor tyrosine kinase targets PDGFR-β, VEGFR2 and KIT in canine transitional cell carcinoma.
Walters L; Martin O; Price J; Sula MM
Vet Comp Oncol; 2018 Mar; 16(1):E117-E122. PubMed ID: 28884928
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of ΔNp63 expression in canine transitional cell carcinoma of the urinary bladder.
Nishimori T; Hanazono K; Matsuda K; Kawamura Y; Kadosawa T; Endo Y; Uchide T
Open Vet J; 2021; 11(4):700-706. PubMed ID: 35070867
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of HER-2 via immunohistochemistry in canine urinary bladder transitional cell carcinoma - A marker of malignancy and possible therapeutic target.
Millanta F; Impellizeri J; McSherry L; Rocchigiani G; Aurisicchio L; Lubas G
Vet Comp Oncol; 2018 Jun; 16(2):297-300. PubMed ID: 28871659
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound characteristics of feline urinary bladder transitional cell carcinoma are similar to canine urinary bladder transitional cell carcinoma.
Hamlin AN; Chadwick LE; Fox-Alvarez SA; Hostnik ET
Vet Radiol Ultrasound; 2019 Sep; 60(5):552-559. PubMed ID: 31144408
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor expression in canine transitional cell carcinoma.
Hanazono K; Fukumoto S; Kawamura Y; Endo Y; Kadosawa T; Iwano H; Uchide T
J Vet Med Sci; 2015 Jan; 77(1):1-6. PubMed ID: 25223345
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of the BRAF variant V595E in urine samples, smears and biopsies from canine transitional cell carcinoma].
Aupperle-Lellbach H; Grassinger J; Hohloch C; Kehl A; Pantke P
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2018 Oct; 46(5):289-295. PubMed ID: 30541168
[TBL] [Abstract][Full Text] [Related]
12. Expression of cell cycle regulators, 14-3-3σ and p53 proteins, and vimentin in canine transitional cell carcinoma of the urinary bladder.
Suárez-Bonnet A; Herráez P; Aguirre M; Suárez-Bonnet E; Andrada M; Rodríguez F; Espinosa de Los Monteros A
Urol Oncol; 2015 Jul; 33(7):332.e1-7. PubMed ID: 25979650
[TBL] [Abstract][Full Text] [Related]
13. Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma.
Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Rucker EB; Knapp DW; Rodriguez CO; Green JA
Vet Comp Oncol; 2008 Sep; 6(3):141-50. PubMed ID: 19178674
[TBL] [Abstract][Full Text] [Related]
14. Ultrasonographic findings related to prognosis in canine transitional cell carcinoma.
Hanazono K; Fukumoto S; Endo Y; Ueno H; Kadosawa T; Uchide T
Vet Radiol Ultrasound; 2014; 55(1):79-84. PubMed ID: 23890180
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors.
Ramos-Vara JA; Miller MA; Boucher M; Roudabush A; Johnson GC
Vet Pathol; 2003 Jan; 40(1):55-62. PubMed ID: 12627713
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA profiling of dogs with transitional cell carcinoma of the bladder using blood and urine samples.
Kent MS; Zwingenberger A; Westropp JL; Barrett LE; Durbin-Johnson BP; Ghosh P; Vinall RL
BMC Vet Res; 2017 Nov; 13(1):339. PubMed ID: 29141625
[TBL] [Abstract][Full Text] [Related]
17. Transitional cell carcinoma in fishing cats (Prionailurus viverrinus): pathology and expression of cyclooxygenase-1, -2, and p53.
Landolfi JA; Terio KA
Vet Pathol; 2006 Sep; 43(5):674-81. PubMed ID: 16966444
[TBL] [Abstract][Full Text] [Related]
18. Management of transitional cell carcinoma of the urinary bladder in dogs: a review.
Fulkerson CM; Knapp DW
Vet J; 2015 Aug; 205(2):217-25. PubMed ID: 25747698
[TBL] [Abstract][Full Text] [Related]
19. Assessment of HER2 Expression in Canine Urothelial Carcinoma of the Urinary Bladder.
Tsuboi M; Sakai K; Maeda S; Chambers JK; Yonezawa T; Matsuki N; Uchida K; Nakayama H
Vet Pathol; 2019 May; 56(3):369-376. PubMed ID: 30612533
[TBL] [Abstract][Full Text] [Related]
20. Palliative ultrasound-guided endoscopic diode laser ablation of transitional cell carcinomas of the lower urinary tract in dogs.
Cerf DJ; Lindquist EC
J Am Vet Med Assoc; 2012 Jan; 240(1):51-60. PubMed ID: 22171755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
